Prevalence of Oropharyngeal Candidiasis and distribution of Candida species among People Living with Human Immunodeficiency Virus in Africa: a systematic review and meta-analysis.

Benson Musinguzi, Ekwaro A Obuku, Alison Annet Kinengyere, Regina Ndagire, Andrew Baguma, Alex Mwesigwa, Herbert Itabangi, Gerald Mboowa, Obondo James Sande, Beatrice Achan
{"title":"Prevalence of Oropharyngeal Candidiasis and distribution of <i>Candida</i> species among People Living with Human Immunodeficiency Virus in Africa: a systematic review and meta-analysis.","authors":"Benson Musinguzi, Ekwaro A Obuku, Alison Annet Kinengyere, Regina Ndagire, Andrew Baguma, Alex Mwesigwa, Herbert Itabangi, Gerald Mboowa, Obondo James Sande, Beatrice Achan","doi":"10.21203/rs.3.rs-4534730/v1","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>The incidence of oropharyngeal candidiasis among people living with human immunodeficiency virus in Africa is on the rise. Oropharyngeal candidiasis is mainly caused by <i>C.albicans</i>; however, a shift in the etiology towards non-<i>Candida albicans</i> species is increasing. In addition, there are variations in the epidemiological distribution of <i>Candida</i> species causing oropharyngeal candidiasis among people living with human immunodeficiency virus in Africa.</p><p><strong>Objective: </strong>This review aimed to determine the prevalence of oropharyngeal candidiasis and the distribution of <i>Candida</i> species among people living with human immunodeficiency virus in Africa.</p><p><strong>Materials and methods: </strong>This systematic review protocol was registered in the base PROSPERO database prior to its conduct (CRD42021254473). The Preferred Reporting Items for Systematic Reviews and Meta-Analyses Protocol guidelines (PRISMA-P) were followed for this study. The PubMed, Scopus and EMBASE databases were searched to identify published studies published between 1<sup>st</sup> January 2000 and 8<sup>th</sup> October 2022. The eligible studies were included in the meta-analysis and analyzed using a random effects model. The risk of bias of the included studies was assessed using the Joanna Briggs Institute quality assessment tool for prevalence studies.</p><p><strong>Results: </strong>The database search yielded 370 titles from PubMed (n=192), EMBASE (n=162) and SCOPUS (n=16). Fourteen studies with a total of 3,863 participants were included in the meta-analysis. The pooled prevalence of oropharyngeal candidiasis was 49.0% (95% CI: 37% - 62%). A total of 2,688 <i>Candida</i> isolates were reported; approximately 76.6% (n=2,060) were <i>C. albicans</i>, and 21.7% (n=582) were non-<i>C. albicans</i>. Among the non-<i>Candida albicans</i> species, <i>C</i>. <i>glabrata</i> was the most common isolate (29.6%), followed by <i>C</i>. <i>tropicalis</i> (27.7%), <i>C</i>. <i>krusei</i> (17.0%), <i>C</i>. <i>parapsilosis</i> (8.1%) and <i>C</i>. <i>dubliniensis</i> (5.2%). Out of 14 studies, 7 (50.0%) had a low risk of bias, 5 (35.7%) had a moderate risk of bias, and 2 (14.3%) had a high risk of bias.</p><p><strong>Conclusion: </strong>Almost half of people living with HIV in Africa have oropharyngeal candidiasis, and <i>C. albicans</i> remains the most frequent cause of oropharyngeal candidiasis.</p>","PeriodicalId":94282,"journal":{"name":"Research square","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-06-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11177986/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Research square","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.21203/rs.3.rs-4534730/v1","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Background: The incidence of oropharyngeal candidiasis among people living with human immunodeficiency virus in Africa is on the rise. Oropharyngeal candidiasis is mainly caused by C.albicans; however, a shift in the etiology towards non-Candida albicans species is increasing. In addition, there are variations in the epidemiological distribution of Candida species causing oropharyngeal candidiasis among people living with human immunodeficiency virus in Africa.

Objective: This review aimed to determine the prevalence of oropharyngeal candidiasis and the distribution of Candida species among people living with human immunodeficiency virus in Africa.

Materials and methods: This systematic review protocol was registered in the base PROSPERO database prior to its conduct (CRD42021254473). The Preferred Reporting Items for Systematic Reviews and Meta-Analyses Protocol guidelines (PRISMA-P) were followed for this study. The PubMed, Scopus and EMBASE databases were searched to identify published studies published between 1st January 2000 and 8th October 2022. The eligible studies were included in the meta-analysis and analyzed using a random effects model. The risk of bias of the included studies was assessed using the Joanna Briggs Institute quality assessment tool for prevalence studies.

Results: The database search yielded 370 titles from PubMed (n=192), EMBASE (n=162) and SCOPUS (n=16). Fourteen studies with a total of 3,863 participants were included in the meta-analysis. The pooled prevalence of oropharyngeal candidiasis was 49.0% (95% CI: 37% - 62%). A total of 2,688 Candida isolates were reported; approximately 76.6% (n=2,060) were C. albicans, and 21.7% (n=582) were non-C. albicans. Among the non-Candida albicans species, C. glabrata was the most common isolate (29.6%), followed by C. tropicalis (27.7%), C. krusei (17.0%), C. parapsilosis (8.1%) and C. dubliniensis (5.2%). Out of 14 studies, 7 (50.0%) had a low risk of bias, 5 (35.7%) had a moderate risk of bias, and 2 (14.3%) had a high risk of bias.

Conclusion: Almost half of people living with HIV in Africa have oropharyngeal candidiasis, and C. albicans remains the most frequent cause of oropharyngeal candidiasis.

非洲人类免疫缺陷病毒感染者口咽念珠菌病患病率和念珠菌种类分布:系统回顾和荟萃分析。
背景:在非洲,人类免疫缺陷病毒感染者口咽念珠菌病的发病率呈上升趋势。口咽念珠菌病主要由白色念珠菌引起,但病因正逐渐转向非白色念珠菌。此外,在非洲人体免疫缺陷病毒感染者中,引起口咽念珠菌病的念珠菌种类在流行病学分布上存在差异。目的:本综述旨在确定非洲人类免疫缺陷病毒感染者中口咽念珠菌病的发病率和念珠菌菌种的分布情况。材料与方法:本系统综述方案在实施前已在 PROSPERO 基础数据库中注册(CRD42021254473)。本研究遵循《系统综述和元分析首选报告项目协议》(PRISMA-P)指南。研究人员检索了 PubMed、Scopus 和 EMBASE 数据库,以确定 2000 年 1 月 1 日至 2022 年 10 月 8 日期间发表的研究。符合条件的研究被纳入荟萃分析,并采用随机效应模型进行分析。采用乔安娜-布里格斯研究所的流行病学研究质量评估工具对纳入研究的偏倚风险进行了评估。结果通过数据库检索,从 PubMed(192 篇)、EMBASE(162 篇)和 SCOPUS(16 篇)中获得了 370 个标题。荟萃分析纳入了 14 项研究,共有 3,863 名参与者。口咽念珠菌病的合计患病率为 49.0%(95% CI:37% - 62%)。共报告了 2,688 株念珠菌分离物,其中约 76.6%(n=2,060)为白念珠菌,21.7%(n=582)为非白念珠菌。在非白色念珠菌物种中,最常见的分离物是格拉布氏念珠菌(29.6%),其次是热带念珠菌(27.7%)、克鲁塞念珠菌(17.0%)、副丝状念珠菌(8.1%)和杜布里尼念珠菌(5.2%)。在14项研究中,7项(50.0%)存在低偏倚风险,5项(35.7%)存在中度偏倚风险,2项(14.3%)存在高度偏倚风险。结论:非洲近一半的艾滋病毒感染者患有口咽念珠菌病,白念珠菌仍是口咽念珠菌病最常见的病因。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信